BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24262072)

  • 1. Morphologic detection of blast cells in the cerebrospinal fluid at diagnosis of adult acute lymphoblastic leukemia appears to be associated with adverse prognosis.
    Ko SY; Chi HS; Jang S; Park CJ
    Int J Lab Hematol; 2014 Aug; 36(4):451-8. PubMed ID: 24262072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.
    Mahmoud HH; Rivera GK; Hancock ML; Krance RA; Kun LE; Behm FG; Ribeiro RC; Sandlund JT; Crist WM; Pui CH
    N Engl J Med; 1993 Jul; 329(5):314-9. PubMed ID: 8321259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of central nervous system involvement at diagnosis of childhood T-cell acute lymphoblastic leukemia.
    Jaing TH; Yang CP; Hung IJ; Tsay PK; Tseng CK; Chen SH
    Pediatr Blood Cancer; 2005 Aug; 45(2):135-8. PubMed ID: 15704218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute count of leukemic blasts in cerebrospinal fluid as detected by flow cytometry is a relevant prognostic factor in children with acute lymphoblastic leukemia.
    Popov A; Henze G; Verzhbitskaya T; Roumiantseva J; Lagoyko S; Khlebnikova O; Streneva O; Bidanov O; Tsaur G; Inaba H; Karachunskiy A; Fechina L
    J Cancer Res Clin Oncol; 2019 May; 145(5):1331-1339. PubMed ID: 30840196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia.
    Jaime-Pérez JC; Borrego-López MF; Jiménez-Castillo RA; Méndez-Ramírez N; Salazar-Riojas R; Fernández LT; Gómez-Almaguer D
    Int J Lab Hematol; 2018 Apr; 40(2):169-174. PubMed ID: 29115725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotyping of the cerebrospinal fluid as a prognostic factor at diagnosis of acute lymphoblastic leukemia in children and adolescents.
    Cancela CSP; Murao M; Assumpção JG; Souza MEL; de Macedo AV; Viana MB; De Oliveira BM
    Pediatr Hematol Oncol; 2017 Mar; 34(2):53-65. PubMed ID: 28548878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.
    Ranta S; Nilsson F; Harila-Saari A; Saft L; Tani E; Söderhäll S; Porwit A; Hultdin M; Noren-Nyström U; Heyman M
    Pediatr Blood Cancer; 2015 Jun; 62(6):951-6. PubMed ID: 25545289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flow cytometric analysis of cerebrospinal fluid in the diagnosis of central nervous system leukemia].
    Jiang NG; Zhu HL; Zeng TT; Su J; Zhang Y; Jia YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):664-8. PubMed ID: 20848792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroleukemia in adults].
    Beslać-Bumbasirević Lj; Bosković D; Tomin D; Colović M; Kovacević M; Bumbasirević V
    Srp Arh Celok Lek; 1996; 124(3-4):82-6. PubMed ID: 9102825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of blasts in low-cell-count cerebrospinal fluid specimens from children with acute lymphoblastic leukemia.
    Odom LF; Wilson H; Cullen J; Bank J; Blake M; Jamieson B
    Cancer; 1990 Oct; 66(8):1748-54. PubMed ID: 2208030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of cerebrospinal fluid in adult patients with acute lymphoblastic leukemia during follow-up.
    Gong X; Lin D; Wang H; Wang Y; Liu B; Wei H; Zhou C; Liu K; Wei S; Gong B; Zhang G; Liu Y; Zhao X; Li Y; Gu R; Qiu S; Mi Y; Wang J
    Eur J Haematol; 2018 Mar; 100(3):279-285. PubMed ID: 29240262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.
    ; te Loo DM; Kamps WA; van der Does-van den Berg A; van Wering ER; de Graaf SS
    J Clin Oncol; 2006 May; 24(15):2332-6. PubMed ID: 16710032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia.
    Levinsen M; Taskinen M; Abrahamsson J; Forestier E; Frandsen TL; Harila-Saari A; Heyman M; Jonsson OG; Lähteenmäki PM; Lausen B; Vaitkevičienė G; Asberg A; Schmiegelow K;
    Pediatr Blood Cancer; 2014 Aug; 61(8):1416-21. PubMed ID: 24623619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction.
    Pine SR; Yin C; Matloub YH; Sabaawy HE; Sandoval C; Levendoglu-Tugal O; Ozkaynak MF; Jayabose S
    J Mol Diagn; 2005 Feb; 7(1):127-32. PubMed ID: 15681484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse.
    Martínez-Laperche C; Gómez-García AM; Lassaletta Á; Moscardó C; Vivanco JL; Molina J; Fuster JL; Couselo JM; de Toledo JS; Bureo E; Madero L; Ramírez M
    Am J Hematol; 2013 May; 88(5):359-64. PubMed ID: 23468276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis of leukemic cerebrospinal fluid cells in children with newly diagnosed acute lymphoblastic leukemia.
    Scrideli CA; Queiroz RP; Takayanagui OM; Bernardes JE; Melo EV; Tone LG
    Haematologica; 2004 Aug; 89(8):1013-5. PubMed ID: 15339689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review.
    Secker-Walker LM; Craig JM
    Leukemia; 1993 Feb; 7(2):147-51. PubMed ID: 8426467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
    Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
    Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case series: CSF LDH, proteins and electrolyte levels in patients of acute lymphocytic leukemia.
    Rao D; Ghalaut VS; Ghalaut PS; Rao S
    Clin Chim Acta; 2012 Jul; 413(13-14):1045-8. PubMed ID: 22387722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.